However, we found unexpectedly that MLKL gene knockout enhanced CRC cell death caused by a protein synthesis inhibitor homoharringtonine used for chronic myeloid leukemia treatment. The gene discussed is MLKL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.